Home - Riboflavins
Riboflavin Solutions for Corneal Cross-Linking. Quality and Safety for Corneal Treatment.



Riboflavin Solutions for Corneal Cross-Linking. Quality and Safety for Corneal Treatment.
Corneal Cross-Linking is an essential advance in the treatment of keratoconus and other corneal diseases, providing greater resistance and stability to corneal tissue. Riboflavin solutions guarantee safe, effective and reliable treatment, meeting the highest quality standards. Riboflavina garantem um tratamento seguro, eficaz e confiável, atendendo aos mais altos padrões de qualidade.
With the confidence of our Riboflavins, healthcare professionals can offer their patients a safe and innovative treatment, promoting the vision preservation and improving their quality of life.
Invest in the best technology for Corneal Cross-Linking with Goldfarma's Riboflavin solutions.
By using our Riboflavin solutions, you guarantee:
Corneal Cross-Linking is an essential advance in the treatment of keratoconus and other corneal diseases, providing greater resistance and stability to corneal tissue. Riboflavin solutions guarantee safe, effective and reliable treatment, meeting the highest quality standards. Riboflavina garantem um tratamento seguro, eficaz e confiável, atendendo aos mais altos padrões de qualidade.
With the confidence of our Riboflavins, healthcare professionals can offer their patients a safe and innovative treatment, promoting the vision preservation and improving their quality of life.
Invest in the best technology for Corneal Cross-Linking with Goldfarma's Riboflavin solutions.
By using our Riboflavin solutions, you guarantee:
Goldfarma Comércio de Produtos Farmacêuticos Lda., has notified Infarmed within the scope of the exercise of the activities of Distribution of Medicines and Medical Devices. NIPC 507372328
Goldfarma Comércio de Produtos Farmacêuticos Lda., has notified Infarmed within the scope of the exercise of the activities of Distribution of Medicines and Medical Devices. NIPC 507372328
goldfarma © 2025 all rights reserved